As of November 6, 2026, MeiraGTx Holdings plc has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on September 23, 2026, naming 1 appointment. The latest filing names Alan M. Sebulsky, appointed (Form 8-K, September 23, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like MeiraGTx Holdings plc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
MeiraGTx Holdings plc reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-09-23. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as MeiraGTx Holdings plc files it.
Also on the record for MeiraGTx Holdings plc
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 14, 2026 | Stake report, Schedule 13G/A, by Rubric Capital Management LP | 9.83% of the class | 5%+ stakes | Source |
| May 13, 2026 | Stake report, Schedule 13G/A, by Adage Capital Management, L.P. | 4.91% of the class | 5%+ stakes | Source |
| April 24, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 12.6% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G, by Rubric Capital Management LP | 7.9% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Prosight Management, LP | 4% of the class | 5%+ stakes | Source |
| January 2, 2026 | Stake report, Schedule 13D/A, by Perceptive Advisors LLC | 12.9% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Adage Capital Management, L.P. | 5.2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs MeiraGTx Holdings plc now and the warning signs.
Free to see. No signup.
Keep reading
More on MeiraGTx Holdings plc and the records around it.
MeiraGTx Holdings plc elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Prosight Management, LP also filed stake reports on 5 other companies: OnKure Therapeutics, Inc. (Aug 2026), ADC Therapeutics SA (Feb 2026), Janux Therapeutics, Inc. (Feb 2026)
- Rubric Capital Management LP also filed stake reports on 32 other companies: ARDELYX, INC. (Aug 2026), Enovis Corporation (Aug 2026), Mission Produce, Inc. (Aug 2026)
- Perceptive Advisors LLC also filed stake reports on 57 other companies: Nautilus Biotechnology, Inc. (Nov 2026), Athira Pharma, Inc. (Oct 2026), IRulya Therapeutics Inc. (Oct 2026)
Watch MeiraGTx Holdings plc
Get an email when MeiraGTx Holdings plc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on MeiraGTx Holdings plc?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on MeiraGTx Holdings plc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on MeiraGTx Holdings plc covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-23 | In | 8-K, 2026-09-23 |
New leaders reset buying decisions — get the Full Report on MeiraGTx Holdings plc: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at MeiraGTx Holdings plc, with the record behind each one.
Find candidates like senior executive at MeiraGTx Holdings plcEvery change, in the filing's words
Appointed: Alan M. Sebulsky
Mr. Sebulsky has been appointed to serve as a member of the Science and Technology Committee.
- On September 22, 2026, the Board of Directors (the "Board") of MeiraGTx Holdings plc (the "Company"), upon the recommendation of its Nominating and Corporate Governance Committee, appointed Alan M. Sebulsky to the Board as a Class I director, effective September 23, 2026, with a term that expires at the Company's 2028 annual meeting of shareholders when Class I directors are up for re-election and until his successor is duly elected and qualified.
- Mr. Sebulsky was recommended as a potential candidate for election to our Board by the Company's senior management.
- Mr. Sebulsky has served as the Managing Member of Apothecary Capital LLC since its reestablishment in April 2026.
- Mr. Sebulsky previously served as a Partner and Portfolio Manager at Adage Capital Management, LP. from July 2012 to April 2026, where he was responsible for managing a biopharmaceutical portfolio.
- Prior to that Mr. Sebulsky served as a Portfolio Manager at BBT Capital Management Advisory LLC from April 2003 to March 2012, through his role as the Managing Partner of Apothecary Capital LLC over the same period.
- From 1994 to 2002, Mr. Sebulsky held various positions, including as a Managing Director at Lincoln Capital Management, a private investment management firm, where he was responsible for investments in the healthcare industry.
Tools for this story
Each opens in a new tab, filled in for MeiraGTx Holdings plc. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.